MYRON Z. HOLUBIAK - 03 Apr 2024 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
03 Apr 2024
Net transactions value
$0
Form type
4
Filing time
05 Apr 2024, 16:05:20 UTC
Previous filing
12 Oct 2023
Next filing
14 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 1,992,243 03 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Warrant to Purchase Common Stock Disposed to Issuer -129,450 -100% 0 03 Apr 2024 Common Stock 129,450 $1.42 Direct F1
transaction CTXR Warrant to Purchase Common Stock Award +129,450 129,450 03 Apr 2024 Common Stock 129,450 $1.42 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 400,000 03 Apr 2024 Common Stock 400,000 $0.7000 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 400,000 03 Apr 2024 Common Stock 400,000 $1.25 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 650,000 03 Apr 2024 Common Stock 650,000 $2.04 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 15,000 03 Apr 2024 Common Stock 15,000 $2.04 See footnote F5
holding CTXR Stock Option (Right to Purchase Common Stock) 300,000 03 Apr 2024 Common Stock 300,000 $2.00 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 10,000 03 Apr 2024 Common Stock 10,000 $2.00 See footnote F5
holding CTXR Stock Option (Right to Purchase Common Stock) 200,000 03 Apr 2024 Common Stock 200,000 $1.01 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 175,000 03 Apr 2024 Common Stock 175,000 $0.6700 Direct F8
holding CTXR Warrant to Purchase Common Stock 558,597 03 Apr 2024 Common Stock 558,597 $0.7700 Direct F9
holding CTXR Stock Option (Right to Purchase Common Stock) 150,000 03 Apr 2024 Common Stock 150,000 $1.62 Direct F10
holding CTXR Stock Option (Right to Purchase Common Stock) 40,000 03 Apr 2024 Common Stock 40,000 $3.45 Direct F11
holding CTXR Stock Option (Right to Purchase Common Stock) 26,667 03 Apr 2024 Common Stock 26,667 $8.10 Direct F12
holding CTXR Warrant to Purchase Common Stock 784,314 03 Apr 2024 Common Stock 784,314 $1.15 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.
F2 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F3 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F4 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F5 The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
F6 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F7 The options vested in full on October 6, 2023.
F8 The options vested in full on October 8, 2022.
F9 The warrant is fully vested and exercisable immediately.
F10 The options vested in full on September 4, 2021.
F11 The options vested in full on September 13, 2020.
F12 The options vested in full on December 31, 2016.